ReviewNew microbes and new infections2025
Bloodstream infections in Cameroon: a systematic review and meta-analysis.
Review in New microbes and new infections, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Genomic epidemiology of extended-spectrum beta-lactamase-producingJAC-antimicrobial resistance · 2026Article
- Trends of antimicrobial resistance in bloodstream infections at a large traditional Chinese medicine hospital in China: a 10-year surveillance study (2015-2024).BMC infectious diseases · 2026Article
- Neonatal sepsis in Cameroon: A call for a national registry and surveillance to bridge data and action gaps.New microbes and new infections · 2025Article
- Bacterial etiology and antimicrobial resistance in bloodstream infections at the University of Gondar Comprehensive Specialized Hospital: a cross-sectional study.Frontiers in microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Bloodstream infections (BSIs) are significantly associated with morbidity and mortality worldwide, and particularly in low-resource settings. We determined the prevalence of BSIs, profile, and antimicrobial resistance of the causing bacteria in Cameroon. Methods: PubMed, Google Scholar and ScienceDirect databases were searched to identify relevant studies. The random or fixed effect model was used depending on the level of heterogeneity among studies for pooling estimates after the variance was stabilised through the Freeman-Tukey double arcsine transformation. Begg's and Egger's tests were used to quantify publication bias. The protocol was registered in PROSPERO (CRD42023482760). Results: The analysis of 5680 blood cultures from ten studies revealed an overall bacterial BSI prevalence of 25.2 % (95 % CI: 18.1-33.2 %) and 17.2 % (11.6-23.7 %) when the potential contaminants were removed. The leading BSI-causing bacteria were Conclusion: This study reports a substantial prevalence of BSI and resistance to the commonly used antibiotics. It also points out the lack of compliance with international guidelines in microbiological analysis. This highlights the need to empower laboratories' capacities and conduct BSI surveillance across the country to develop more targeted strategies for the prevention, management and treatment of BSIs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.